by 
The automated cell counters market has witnessed significant growth over the past few years owing to the advantages it offers over manual cell counters such as accuracy, simplicity, cost-effectiveness, and high-throughput analysis. Automated cell counters help automate the tedious and time-consuming task of manual cell counting. They help in counting a large number of cells precisely in a reliable and reproducible manner. Automated cell counters are being widely used in research institutes and pharmaceutical companies for cell line development, cell biology research, and drug discovery activities.
The global automated cell counters market is estimated to be valued at US$ 3.75 billion in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan.
The emergence of novel applications of cell counting such as in cell-based assays, viability testing, apoptosis testing, and cell proliferation assays is expected to present lucrative growth opportunities for players in the automated cell counters market.
Growing demand for accurate and precise cell analysis from emerging regions of Asia Pacific and Latin America owing to increasing pharmaceutical research is expected to drive the global expansion of the automated cell counters market over the forecast period.
Market Drivers
The increasing adoption of lab automation solutions in research laboratories and healthcare facilities is a major factor driving the growth of the automated cell counters market. Automated cell counters help save time and effort involved in manual cell counting. This is encouraging more research institutes and pharma companies to automate their cell analysis processes using advanced cell counters. The rising R&D expenditure on drug discovery and growing cell-based research are further augmenting the demand for automated cell counters.
PEST Analysis
Political: Regulations related to healthcare devices manufacturing and approvals for new medical devices are becoming more stringent. This increases pressure on companies to comply with quality and safety standards.
Economic: Growth in the healthcare industry due to rising government investments, increasing healthcare expenditures and demand for advanced diagnostic technologies is driving market growth.
Social: Increasing prevalence of chronic and infectious diseases is generating demand for faster, more affordable and accurate diagnostic tests. Growing emphasis on early detection of diseases also supports market growth.
Technological: Adoption of automation, digitalization and artificial intelligence is enhancing capabilities of cell counters. Integration of microfluidic lab-on-a-chip technologies enables developing compact and portable devices for point-of-care testing.
Geographical Regions of Concentration
North America dominates the automated cell counters market in terms of value due to modern healthcare infrastructure, availability of advanced diagnostic technologies and rising burden of chronic diseases. Presence of leading manufacturers and availability of reimbursements for diagnostic tests also contributes to high market share of the region.
Fastest Growing Region
Asia Pacific is projected to be the fastest growing regional market during the forecast period owing to increasing healthcare spending, large population base, rising awareness about disease diagnostics and growing demand for point-of-care testing in countries such as China and India. Expanding healthcare facilities, improving access to diagnostics and growing geriatric population are factors expected to fuel regional market growth.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
